BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Allergy to pollen
,
Intestine
,
Anticancer prodrugs
,
BRAF
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bromodomains
Summary
General Info
Curated Studies
Most Correlated Studies
Bromodomain-dependent stage-specific male genome programming by Brdt
Multiple myeloma cells treated with BET-bromodomain inhibitor JQ1
CD4+ T cells in Th17-promoting conditions treated with bromodomain inhibitors
Burkitt lymphoma RAJI cells treated with bromodomain and extraterminal motif inhibitor JQ1
Pancreatic ductal cancer cell lines treated with the BET bromodomain inhibitor CPI203
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer.
Selectively targeting individual bromodomain: Drug discovery and molecular mechanisms.
Uncovering the non-histone interactome of the BRPF1 bromodomain using site-specific azide-acetyllysi…
Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimi…
DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitor BMS-986158 in Pediatric Can…
A Dose-Finding Study of MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (B…
A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/MK-8628 in Hematologic Malignancies (…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ